Rave drugs: pharmacological considerations
- PMID: 15529726
Rave drugs: pharmacological considerations
Comment on
-
Rave drugs: pharmacological considerations.AANA J. 2004 Feb;72(1):61-7. AANA J. 2004. PMID: 15098519 Review.
Similar articles
-
From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy.Pharmacotherapy. 2003 Sep;23(9):1205-9. doi: 10.1592/phco.23.10.1205.32756. Pharmacotherapy. 2003. PMID: 14524654 Clinical Trial.
-
Xyrem approved for muscle problems in narcolepsy.FDA Consum. 2002 Sep-Oct;36(5):7. FDA Consum. 2002. PMID: 12412541 No abstract available.
-
[Gammahydroxybutyrate must remain available for patients with narcolepsy].Ned Tijdschr Geneeskd. 1999 Oct 9;143(41):2062-3. Ned Tijdschr Geneeskd. 1999. PMID: 10560549 Dutch.
-
[GHB--dangerous, addictive and uncontrollable "party drug"].Lakartidningen. 2001 Sep 19;98(38):4026-31, 4033-5. Lakartidningen. 2001. PMID: 11602959 Review. Swedish.
-
Sodium oxybate for cataplexy.Ann Pharmacother. 2006 Mar;40(3):433-40; quiz 581-2. doi: 10.1345/aph.1G456. Epub 2006 Feb 28. Ann Pharmacother. 2006. PMID: 16507620 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical